Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review
The safety of COVID-19 pharmacotherapy is a relevant issue, first of all, because of the current lack of experience with using particular medicinal products and with off-label prescribing. The aim of the study was to analyse information on potential adverse drug reactions (ADRs) and their predictors...
Saved in:
Main Authors: | A. V. Kryukov (Author), A. S. Zhiryakova (Author), Yu. V. Shevchuk (Author), A. V. Matveev (Author), V. I. Vechorko (Author), O. V. Averkov (Author), S. V. Glagolev (Author), I. I. Temirbulatov (Author), K. B. Mirzaev (Author), N. P. Denisenko (Author), Sh. P. Abdullaev (Author), D. A. Sychev (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Model for predicting risk of developing drug-induced liver injury during remdesivir therapy: observational prospective open case-control study
by: Yu. V. Shevchuk, et al.
Published: (2023) -
Variation of Genomic Sites Associated with Severe Covid-19 Across Populations: Global and National Patterns
by: Balanovsky O, et al.
Published: (2021) -
Patients' Pharmacogenetic Characteristics and the Risk of Adverse Reactions to Non-steroidal Anti-inflammatory Drugs: Case Reports
by: A. S. Zhiryakova, et al.
Published: (2024) -
Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis
by: l. V. Fedina, et al.
Published: (2024) -
Clinical Signs and Medical History as Predictors of Enalapril-Associated Dry Cough in Cardiovascular Patients
by: I. V. Sychev, et al.
Published: (2023)